ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+10.24%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$711M
AUM Growth
+$711M
(-25%)
Cap. Flow
-$281M
Cap. Flow
% of AUM
-39.53%
Top 10 Holdings %
Top 10 Hldgs %
65.39%
Holding
37
New
13
Increased
1
Reduced
10
Closed
13
Top Buys
| 1 |
Medpace
MEDP
|
$64.4M |
| 2 |
Illumina
ILMN
|
$57.4M |
| 3 |
Tenet Healthcare
THC
|
$51.3M |
| 4 |
Envista
NVST
|
$43.3M |
| 5 |
Exact Sciences
EXAS
|
$27.2M |
Top Sells
| 1 |
Edwards Lifesciences
EW
|
$67.2M |
| 2 |
DexCom
DXCM
|
$66M |
| 3 |
McKesson
MCK
|
$53.8M |
| 4 |
AbbVie
ABBV
|
$48.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$45.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Agilon Health
AGL
$530M
| – | – | -2,519,416 | Closed | -$16.5M |
|
27
argenx
ARGX
$43.6B
| – | – | -61,704 | Closed | -$26.5M |
|
|
28
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – | -555,140 | Closed | -$45.7M |
|
|
29
DexCom
DXCM
$29.5B
| – | – | -582,199 | Closed | -$66M |
|
|
30
Edwards Lifesciences
EW
$47.8B
| – | – | -727,180 | Closed | -$67.2M |
|
31
Inspire Medical Systems
INSP
$2.77B
| – | – | -281,992 | Closed | -$37.7M |
|
32
908 Devices
MASS
$226M
| – | – | -728,865 | Closed | -$3.75M |
|
|
33
McKesson
MCK
$85.4B
| – | – | -92,125 | Closed | -$53.8M |
|
34
Neurocrine Biosciences
NBIX
$13.8B
| – | – | -200,000 | Closed | -$27.5M |
|
35
Schrodinger
SDGR
$1.44B
| – | – | -1,133,102 | Closed | -$21.9M |
|
36
West Pharmaceutical
WST
$17.8B
| – | – | -132,908 | Closed | -$43.8M |
|
|
ALMS
37
Alumis Inc. Common Stock
ALMS
$479M
| – | – | -125,000 | Closed | -$1.66M |
|